Evaluation of the effects of 18 non-synonymous single-nucleotide polymorphisms of CYP450 2C19 on in vitro drug inhibition potential by a fluorescence-based high-throughput assay

By Wang Huijuan   Kim Raymond A.   Sun Dongxu   Gao Yiwen   Wang Hao   Zhu Juanli   Chen Chao  

Xenobiotica, Vol. 41, Iss. 9, 2011-09 ,pp. : 826-835

Informa Healthcare

Access to resources Recommend Favorite

Prediction of in vivo drug interactions with eplerenone in man from in vitro metabolic inhibition data

By Cook C. S.   Berry L. M.   Burton E.  

Xenobiotica, Vol. 34, Iss. 3, 2004-03 ,pp. : 215-228

Informa Healthcare

Access to resources Recommend Favorite

Functional characterization of two novel CYP2C19 variants (CYP2C19*18 and CYP2C19*19) found in a Japanese population

By Hanioka N.   Hanioka N.   Tsuneto Y.   Saito Y.   Sumada T.   Maekawa K.   Saito K.   Sawada J.   Narimatsu S.  

Xenobiotica, Vol. 37, Iss. 4, 2007-10 ,pp. : 342-355

Informa Healthcare

Access to resources Recommend Favorite

Studies on the induction of rat hepatic CYP1A, CYP2B, CYP3A and CYP4A subfamily form mRNAs in vivo and in vitro using precision-cut rat liver slices

By Meredith C.   Scott M. P.   Renwick A. B.   Price R. J.   Lake B. G.  

Xenobiotica, Vol. 33, Iss. 5, 2003-01 ,pp. : 511-527

Informa Healthcare

Access to resources Recommend Favorite

Genetic polymorphisms of cytochrome P450 2C9 causing reduced phenprocoumon (S)-7-hydroxylation in vitro and in vivo

By Ufer M.   Kammerer B.   Kahlich R.   Kirchheiner J.   Yasar ü.   brockmöller J.   Rane A.  

Xenobiotica, Vol. 34, Iss. 9, 2004-09 ,pp. : 847-859

Informa Healthcare

Access to resources Recommend Favorite